FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2227542431> ?p ?o ?g. }

• W2227542431 endingPage "1015" @default.
• W2227542431 startingPage "1009" @default.
• W2227542431 abstract "Purpose The aim of this study was to evaluate the cost-effectiveness of nivolumab versus ipilimumab for the treatment of previously untreated patients with BRAF-advanced melanoma (BRAF-AM) from an Australian health system perspective. Methods A state-transition Markov model was constructed to simulate the progress of Australian patients with BRAF-AM. The model had a 10-year time horizon with outcomes discounted at 5% annually. For the nivolumab group, risks of progression and death were based on those observed in the nivolumab arm of a phase III trial (nivolumab vs. dacarbazine). Progression-free survival and overall survival were extrapolated using parametric survival modeling with a log-logistic distribution. In the absence of head-to-head evidence, overall survival and progression-free survival for ipilimumab were estimated on the basis of an indirect comparison using published data. Costs of managing AM were estimated from a survey of Australian clinicians. The cost of ipilimumab was based on the reimbursement price in Australia. The cost of nivolumab was based on expected reimbursement prices in Australia. Quality-of-life data were obtained within the trial using the EuroQol five-dimensional questionnaire. Results Compared with ipilimumab, nivolumab therapy over 10 years was estimated to yield 1.58 life-years and 1.30 quality-adjusted life-years per person, at a (discounted) net cost of US $39,039 per person. The incremental cost-effectiveness ratios for nivolumab compared with ipilimumab were US $25,101 per year of life saved and $30,475 per quality-adjusted life-year saved. Conclusions Nivolumab is a cost-effective means of preventing downstream mortality and morbidity in patients with AM compared with ipilimumab in the Australian setting." @default.
• W2227542431 created "2016-06-24" @default.
• W2227542431 creator A5013124337 @default.
• W2227542431 creator A5015450904 @default.
• W2227542431 creator A5065756310 @default.
• W2227542431 creator A5081507061 @default.
• W2227542431 creator A5082008789 @default.
• W2227542431 creator A5090549280 @default.
• W2227542431 date "2016-12-01" @default.
• W2227542431 modified "2023-09-25" @default.
• W2227542431 title "A Cost-Effectiveness Analysis of Nivolumab Compared with Ipilimumab for the Treatment of BRAF Wild-Type Advanced Melanoma in Australia" @default.
• W2227542431 cites W1534815147 @default.
• W2227542431 cites W1950572133 @default.
• W2227542431 cites W1977421088 @default.
• W2227542431 cites W1981989535 @default.
• W2227542431 cites W1993655814 @default.
• W2227542431 cites W1995200019 @default.
• W2227542431 cites W1998861351 @default.
• W2227542431 cites W2019607817 @default.
• W2227542431 cites W2021792499 @default.
• W2227542431 cites W2030467932 @default.
• W2227542431 cites W2032397328 @default.
• W2227542431 cites W2040851929 @default.
• W2227542431 cites W2057586884 @default.
• W2227542431 cites W2061382057 @default.
• W2227542431 cites W2069592230 @default.
• W2227542431 cites W2097995306 @default.
• W2227542431 cites W2101713088 @default.
• W2227542431 cites W2102031533 @default.
• W2227542431 cites W2104998041 @default.
• W2227542431 cites W2110046944 @default.
• W2227542431 cites W2114972737 @default.
• W2227542431 cites W2128035403 @default.
• W2227542431 cites W2132066361 @default.
• W2227542431 cites W2133075384 @default.
• W2227542431 cites W2135480474 @default.
• W2227542431 cites W2137578070 @default.
• W2227542431 cites W2137723371 @default.
• W2227542431 cites W2155104279 @default.
• W2227542431 cites W2166662937 @default.
• W2227542431 cites W2330366745 @default.
• W2227542431 cites W2473786944 @default.
• W2227542431 cites W4241343949 @default.
• W2227542431 doi "https://doi.org/10.1016/j.jval.2016.05.013" @default.
• W2227542431 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27987627" @default.
• W2227542431 hasPublicationYear "2016" @default.
• W2227542431 type Work @default.
• W2227542431 sameAs 2227542431 @default.
• W2227542431 citedByCount "25" @default.
• W2227542431 countsByYear W22275424312014 @default.
• W2227542431 countsByYear W22275424312016 @default.
• W2227542431 countsByYear W22275424312017 @default.
• W2227542431 countsByYear W22275424312018 @default.
• W2227542431 countsByYear W22275424312019 @default.
• W2227542431 countsByYear W22275424312020 @default.
• W2227542431 countsByYear W22275424312021 @default.
• W2227542431 countsByYear W22275424312022 @default.
• W2227542431 crossrefType "journal-article" @default.
• W2227542431 hasAuthorship W2227542431A5013124337 @default.
• W2227542431 hasAuthorship W2227542431A5015450904 @default.
• W2227542431 hasAuthorship W2227542431A5065756310 @default.
• W2227542431 hasAuthorship W2227542431A5081507061 @default.
• W2227542431 hasAuthorship W2227542431A5082008789 @default.
• W2227542431 hasAuthorship W2227542431A5090549280 @default.
• W2227542431 hasConcept C112930515 @default.
• W2227542431 hasConcept C121608353 @default.
• W2227542431 hasConcept C126322002 @default.
• W2227542431 hasConcept C143998085 @default.
• W2227542431 hasConcept C159110408 @default.
• W2227542431 hasConcept C160735492 @default.
• W2227542431 hasConcept C162324750 @default.
• W2227542431 hasConcept C2776694085 @default.
• W2227542431 hasConcept C2777701055 @default.
• W2227542431 hasConcept C2779703844 @default.
• W2227542431 hasConcept C2779900020 @default.
• W2227542431 hasConcept C2779951463 @default.
• W2227542431 hasConcept C2780030458 @default.
• W2227542431 hasConcept C2780739268 @default.
• W2227542431 hasConcept C2780964509 @default.
• W2227542431 hasConcept C2781433595 @default.
• W2227542431 hasConcept C3019080777 @default.
• W2227542431 hasConcept C3019894029 @default.
• W2227542431 hasConcept C50522688 @default.
• W2227542431 hasConcept C64332521 @default.
• W2227542431 hasConcept C71924100 @default.
• W2227542431 hasConceptScore W2227542431C112930515 @default.
• W2227542431 hasConceptScore W2227542431C121608353 @default.
• W2227542431 hasConceptScore W2227542431C126322002 @default.
• W2227542431 hasConceptScore W2227542431C143998085 @default.
• W2227542431 hasConceptScore W2227542431C159110408 @default.
• W2227542431 hasConceptScore W2227542431C160735492 @default.
• W2227542431 hasConceptScore W2227542431C162324750 @default.
• W2227542431 hasConceptScore W2227542431C2776694085 @default.
• W2227542431 hasConceptScore W2227542431C2777701055 @default.
• W2227542431 hasConceptScore W2227542431C2779703844 @default.
• W2227542431 hasConceptScore W2227542431C2779900020 @default.
• W2227542431 hasConceptScore W2227542431C2779951463 @default.
• W2227542431 hasConceptScore W2227542431C2780030458 @default.

• next